PMID- 18925890 OWN - NLM STAT- MEDLINE DCOM- 20090707 LR - 20151119 IS - 1398-9995 (Electronic) IS - 0105-4538 (Linking) VI - 63 IP - 11 DP - 2008 Nov TI - IgE antibodies to omega-5 gliadin associate with immediate symptoms on oral wheat challenge in Japanese children. PG - 1536-42 LID - 10.1111/j.1398-9995.2008.01753.x [doi] AB - BACKGROUND: Gliadins have been implicated in immunoglobulin E (IgE)-mediated allergy to ingested wheat and omega-5-gliadin is known to represent a major allergen in wheat-dependent exercise-induced anaphylaxis. Less known is whether omega-5-gliadin is a clinically relevant allergen in children with immediate allergy to ingested wheat. This study investigates whether specific IgE antibodies to omega-5-gliadin (sIgE-omega-5-gliadin-ab) could be used as a marker for oral wheat challenge outcome in wheat-sensitized children. A secondary objective was to study whether the level of sIgE-omega-5-gliadin was related to symptom severity in children with a positive challenge test. METHODS: Serum samples from 88 children sensitized to wheat, of whom 35 underwent wheat challenge, were collected consecutively. sIgE-omega-5-gliadin-ab was related to a physician's diagnosis of wheat allergy and challenge symptoms. RESULTS: The mean concentration of sIgE-omega-5-gliadin-ab was 7.25 kU(A)/l in patients with wheat allergy and 1.08 kU(A)/l in patients with no wheat allergy (P < 0.01). sIgE-omega-5-gliadin-ab was only detected in 12 of the non-wheat allergic children and 11 of them had a specific IgE to wheat below 1.30 kU(A)/l. Children reacting with severe symptoms upon challenge (n = 8) had increased levels of sIgE-omega-5-gliadin-ab compared to children with moderate, mild or no symptoms (P < 0.001). CONCLUSIONS: The presence of sIgE-omega-5-gliadin-ab is related to the reaction level to wheat challenge outcome in wheat-sensitized children. The sIgE-omega-5-gliadin-ab was found to be associated with a strong convincing history of wheat allergy also in those cases when oral food challenge was avoided. The sIgE-omega-5-gliadin-ab level may serve as a marker for clinical reactivity in wheat-sensitized individuals. FAU - Ito, K AU - Ito K AD - Department of Allergy, Aichi Children's Health and Medical Center, Obu, Japan. FAU - Futamura, M AU - Futamura M FAU - Borres, M P AU - Borres MP FAU - Takaoka, Y AU - Takaoka Y FAU - Dahlstrom, J AU - Dahlstrom J FAU - Sakamoto, T AU - Sakamoto T FAU - Tanaka, A AU - Tanaka A FAU - Kohno, K AU - Kohno K FAU - Matsuo, H AU - Matsuo H FAU - Morita, E AU - Morita E LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Denmark TA - Allergy JT - Allergy JID - 7804028 RN - 0 (Allergens) RN - 0 (Antigens, Plant) RN - 0 (omega-5 gliadin, wheat) RN - 37341-29-0 (Immunoglobulin E) RN - 9007-90-3 (Gliadin) SB - IM MH - Allergens/*immunology MH - Antigens, Plant MH - Child MH - Child, Preschool MH - Female MH - Gliadin/*immunology MH - Humans MH - Immunoglobulin E/*blood MH - Infant MH - Japan MH - Male MH - Mouth/*immunology MH - Triticum/*immunology MH - Wheat Hypersensitivity/blood/*immunology EDAT- 2008/10/18 09:00 MHDA- 2009/07/08 09:00 CRDT- 2008/10/18 09:00 PHST- 2008/10/18 09:00 [pubmed] PHST- 2009/07/08 09:00 [medline] PHST- 2008/10/18 09:00 [entrez] AID - ALL1753 [pii] AID - 10.1111/j.1398-9995.2008.01753.x [doi] PST - ppublish SO - Allergy. 2008 Nov;63(11):1536-42. doi: 10.1111/j.1398-9995.2008.01753.x.